An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: CDER Offices and Divisions

Office of Neuroscience - Division of Neurology II

The Division of Neurology II (DN II) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of seizures, epilepsies, medical countermeasures, migraine, other headaches, traumatic brain Injury, inner ear disorders, stroke, and neuroimmunologic disorders (e.g., Multiple Sclerosis).

Contact Us

Mailing Address

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Neurology (DN II)
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2250
Fax: (301) 796-9842

OND Office and Division Contact Information (PDF)

Resources For You

Top